Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07516977) titled 'Noseguard for Prevention of Respiratory Infections in Real-World Use' on April 1.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: Daewoong Pharmaceutical Co. LTD.
Condition:
Respiratory Infection Virus
COVID-19
Influenza
Intervention:
Device: Noseguard and Noseguard Night
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: April 20, 2026
Target Sample Size: 2000
Countries of Recruitment:
South Korea
To know more, visit https://clinicaltrials.gov/study/NC...